For all you Canadians ...

[JC145]

Delivery system licensed by U of Toronto offers new ovarian cancer treatment  
August 6th, 2008 by David Schwartz under Tech Transfer  

Also on the drug delivery front, the University of Toronto’s Innovations Group has licensed a new system designed to treat ovarian cancer without the crippling side effects of chemotherapy. University researchers recently developed a drug delivery system called PoLi that targets ovarian tumors directly. The PoLi system circumvents the side effects associated with intravenous chemo drugs because it is implanted directly into the tumor site during surgery. It steadily releases drugs directly into the site over a two-month period and then dissolves naturally — no surgical removal is required. The license agreement to develop the technology is with iCo Therapeutics, a Vancouver-based biotechnology company. PoLi is also showing promise in the treatment of other cancers, including head and neck. In addition, the company is developing an injectable gel-based formulation that could be administered directly to tumor sites without any surgery. Go to: The University of Toronto

[TrudieC]

This is wonderful news!  I would also like to point out that there is going to be an international conference on Ovarian Cancer in September in Montreal called Voices of Hope.  It would be so wonderful if someone from the forum could attend and update the rest on some of the latest and greatest.

[survivor_susie]

OMG!  What terrific news.  Such an incredible innovation.  There is hope on the horizon.
Thanks for telling us about this.